High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosisRichard A. Nash, George H. Kraft, James D. Bowen et al.|Blood|2003Cited by 221
Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseasesRichard A. Nash, Peter A. McSweeney, Roger Dansey et al.|Transplantation and Cellular Therapy|2003Cited by 94
Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term resultsJames D. Bowen, RA Nash, George H. Kraft et al.|Bone Marrow Transplantation|2011Cited by 82
Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases)Jan Storek, David G. Maloney, Zhao Zhao et al.|Clinical Immunology|2004Cited by 66
Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: Collaboration of the CIBMTR and EBMT to Facilitate International Clinical StudiesMarcelo C. Pasquini, Riccardo Saccardi, Michael K. Racke et al.|Transplantation and Cellular Therapy|2010Cited by 52